John Hancock Collaborating with Verily and Onduo for Virtual Diabetes Management

John Hancock has unveiled a new wearable program called Aspire, the first of...

Image: Pixabay

John Hancock has unveiled a new wearable program called Aspire, the first of its kind life insurance designed specifically for Americans living with diabetes. The program is a unique collaboration between John Hancock and Verily, the healthcare division of Google parent company Alphabet, and will leverage the capabilities of Onduo, a virtual diabetes clinic.

Read more Fitbit and Health2Synch Partner Up for Diabetes Management

An estimated 1.5 million Americans are diagnosed with diabetes every year. Of the more than 30 million Americans living with diabetes, half either don't have enough life insurance or don't have any life insurance coverage at all. Many worry they won't qualify for a life insurance policy because they have diabetes, and if they can secure coverage they are worried it's too expensive, said a press release.

With John Hancock Aspire people living with diabetes get the protection of life insurance paired with a technology-enabled program that provides coaching, clinical support, education, and rewards designed to help manage and improve their health. All John Hancock Aspire customers will also have access to an enhanced version of John Hancock Vitality, which is designed to reward steps customers take toward living longer, healthier lives, like exercise and buying healthy food, and now offers opportunities specific to the diabetes journey. Members have the potential to save up to 25% on their premiums, the company said.

Onduo app (Image: Onduo)

Qualifying John Hancock Aspire customers with type 2 diabetes will be eligible to access Onduo's virtual clinic and receive a blood glucose monitoring device which, when used in conjunction with the Onduo app, provide insights into the user's diabetes management.

Read more Vitality and New Strategic Partners Focus on Diabetes Prevention and Management and Financial Wellness

“This dynamic partnership with John Hancock unlocks the full potential for the Onduo platform, empowering people living with Type 2 diabetes to co-produce their own health at home and in mobile environments and rewards them for doing so,” Verily CEO Andy Condrad said during an event in Manhattan to announce the new partnership. “Through this initiative, Verily and John Hancock are pushing the envelope on the role life insurance can play in both providing financial security and helping people live longer, healthier lives.”

Sam Draper
October 31, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Macronix Delivers Superior Data Protection in High-Density Memory Devices

Macronix is a leading integrated device manufacturer in the Non-Volatile Memory market.

CardieX Launches New Division to License Advanced Health Data for Consumer Wearables

CardieX, a global health technology company focused on hypertension, cardiovascular disease, and...

Strados Wins FDA Clearance for its Wireless Lung Sound Measurement Platform

Pennsylvania-based Strados Labs has received the FDA’s 510(k) clearance for its Strados RESP...

The First Automated 24/7 Blood Pressure Monitor Comes to the US

Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is...
Discover more